Technology
Health
Pharmaceutical
IDEAYA Biosciences
$6.689876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$6.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.32 (-4.57%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell IDYA and other stocks, options, ETFs, and crypto commission-free!
About IDYA
IDEAYA Biosciences, Inc. Common Stock, also called IDEAYA Biosciences, is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Read More The company operates and manages its business as one operating and reportable segment, which is the business of research and development for oncology-focused precision medicine. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.
Employees
58
Headquarters
South San Francisco, California
Founded
2015
Market Cap
135.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
8.99K
High Today
$6.94
Low Today
$6.70
Open Price
$6.94
Volume
3.52K
52 Week High
$16.90
52 Week Low
$6.55
Collections
Technology
Health
Pharmaceutical
Therapy
Medical
Cancer Prevention
Research And Development
2019 IPO
IDYA Earnings
-$1.56
-$1.39
-$1.21
-$1.04
Q2 2019
Estimated
—
Actual
-$1.30 per share